CURB‑65 Scoring and Clinical Application in Community‑Acquired Pneumonia

Scoring System

• CURB‑65 assigns one point each for: new‑onset confusion, blood urea nitrogen > 7 mmol/L (≈20 mg/dL), respiratory rate ≥ 30 breaths/min, systolic blood pressure < 90 mmHg or diastolic ≤ 60 mmHg, and age ≥ 65 years; the total score ranges from 0 to 5 and guides disposition (outpatient for 0‑1, short‑stay or supervised outpatient for 2, hospital admission with ICU assessment for ≥ 3)【1】【2】.

Risk Stratification & Site‑of‑Care Decisions

These mortality estimates and care recommendations are derived from the original CURB‑65 validation cohort【1】.

Practical Advantages Over Alternative Tools

• The score can be calculated at the bedside using only vital signs and a single laboratory test (urea), enabling rapid point‑of‑care decision‑making【1】.
• In settings where laboratory testing is unavailable, the CRB‑65 variant omits the urea component, producing a four‑point tool usable pre‑hospital or in resource‑limited environments【1】.

Guideline Recommendations (American Thoracic Society/IDSA)

• The 2019 ATS/IDSA guidelines give a conditional recommendation to use CURB‑65 as an adjunct to clinical judgment for disposition decisions in community‑acquired pneumonia, acknowledging its simplicity but noting limited high‑quality evidence for effectiveness【3】.

Critical Limitations and Clinical Caveats

• Underestimation in younger patients – Healthy adults < 65 years without comorbidities may have severe respiratory failure yet score low because hypoxia is not captured【1】【2】.
• Underestimation in older patients with comorbidities – The score may not fully reflect the added risk from chronic illnesses in the elderly【1】.
• Limited sensitivity for ICU‑level care – CURB‑65 identifies only ~61‑78 % of patients who later require mechanical ventilation or vasopressor support, making it less reliable for predicting need for intensive care【2】.
• No oxygenation parameter – Absence of hypoxemia measurement can lead to inappropriate triage of patients with severe respiratory failure but otherwise normal vital signs【2】.

When to Use Alternative Severity Criteria (IDSA/ATS Severe CAP)

• For patients with CURB‑65 ≥ 2 (hospitalized), apply the 2007 IDSA/ATS severe CAP criteria to determine ICU admission【2】.

Major ICU Admission Criteria (any one mandates ICU)

• Requirement for invasive mechanical ventilation【2】.
• Septic shock requiring vasopressor support【2】.

Minor ICU Admission Criteria (≥ 3 of 9 indicate ICU) – cited components

• PaO₂/FiO₂ ≤ 250 mmHg【3】.
• Multilobar infiltrates on chest imaging【2】.
• Thrombocytopenia (platelets < 100,000 /µL)【1】.
• Hypothermia (core temperature < 36 °C)【2】.

These additional criteria address CURB‑65’s blind spots by incorporating oxygenation status and other markers of organ dysfunction【2】.

CURB‑65 Scoring System for Community‑Acquired Pneumonia

Development and Validation

• The British Thoracic Society developed CURB‑65 as a simple, validated clinical prediction tool that uses five readily available parameters to assess severity of community‑acquired pneumonia; the total score (0‑5) correlates directly with 30‑day mortality risk. 4

Scoring Components

• Each of the five components contributes one point:
  
  • Confusion – altered mental status (e.g., new disorientation).
  • Urea – elevated blood urea nitrogen (>7 mmol/L).
  • Respiratory rate – ≥30 breaths per minute.
  • Blood pressure – systolic <90 mmHg or diastolic ≤60 mmHg.
  • Age – ≥65 years.
  • (All components are defined and assigned a point in the original validation study.) [4][5][6][7]

Risk Stratification and Management Recommendations

• Mortality percentages and care recommendations are derived from the original validation cohort. [5][8]

Practical Advantages

• Only simple bedside measurements and a single laboratory test (blood urea) are required, allowing rapid calculation at the point of care. [4][7]9
• A simplified CRB‑65 version (omitting urea) can be employed when laboratory testing is unavailable. [9][10]

Performance Compared with the Pneumonia Severity Index (PSI)

• CURB‑65 shows comparable mortality prediction to PSI while being substantially easier to calculate. 11
• The 2019 American Thoracic Society/IDSA guidelines give a conditional recommendation for CURB‑65 use because of its simplicity, noting that PSI has stronger evidence for effectiveness. 11

Guideline Recommendations (American Thoracic Society / IDSA)

• Low‑risk patients (score 0‑1): reliably identified for outpatient management. [5][11]
• Severe disease (score ≥3): indicates need for hospitalization with ICU assessment. [5][6]
• CURB‑65 should be used as an adjunct to clinical judgment, with final disposition decisions also considering comorbidities, social circumstances, failure of outpatient therapy, and medication access. [9][11]

Limitations and Clinical Caveats

• The score may underestimate severity in younger patients without comorbidities who develop severe respiratory failure, and in elderly patients with significant comorbidities. [5][7]
• Hypoxia is not captured by CURB‑65, and the sensitivity for predicting need for critical‑care interventions is limited (≈78 %). Clinical judgment must therefore override the score when appropriate. [5][7]